Unique clinical imaging dataset to accelerate diagnosis of prostate cancer
The National Cancer Imaging Translational Accelerator has released a unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS).
New ways of tracking people’s diets tested for health benefits
Researchers will try new techniques, including wearable cameras and urine and blood tests, to more accurately measure the UK’s eating habits.
Women who freeze their eggs at 40 are unlikely to have a successful livebirth
A new study has found that women who freeze their eggs at 40 are unlikely to have a successful livebirth when they come to attempt pregnancy.
HPV vaccine alongside removal of cervical lesions may cut cervical cancer risk
A new study finds a reduced risk of cervical cancer recurring after HPV vaccination post-surgery, although further research and trials are needed.
Effect of COVID-19 vaccination on the timing and flow of menstrual periods
A new Imperial study has found that periods can be slightly delayed following a COVID vaccination but return to normal the following cycle.
New collaborative research project to advance cancer therapies
Researchers from Imperial are collaborating with RemedyBio on a novel tumour infiltrating lymphocyte (TILs) discovery approach.
New study shows 95% of new cancer drugs are approved in the US before Europe
Over the last decade, the US FDA is faster to approve new oncology therapies compared with the European EMA; but that speed may have consequences.
Highlighting uncertainty in emergency bowel surgery prediction models
Imperial researchers have created a new model that highlights uncertainty when predicting the risk of death in emergency bowel surgery.
Treatments for varicose veins
A new multicentre randomised clinical trial has compared two different treatment methods for varicose veins.
Kisspeptin reduces liver damage in non-alcoholic fatty liver disease in mice
New research finds that a hormone previously linked to attraction may have the potential to treat liver disease.
